Waldenstrom Macroglobulinemia Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014561096
Market Monitor Global
Oct-2021
Life Sciences
100 Pages

This report contains market size and forecasts of Waldenstrom Macroglobulinemia Therapeutics in global, including the following market information:
Global Waldenstrom Macroglobulinemia Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Waldenstrom Macroglobulinemia Therapeutics Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Waldenstrom Macroglobulinemia Therapeutics companies in 2020 (%)
The global Waldenstrom Macroglobulinemia Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Waldenstrom Macroglobulinemia Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Waldenstrom Macroglobulinemia Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Waldenstrom Macroglobulinemia Therapeutics Market Segment Percentages, By Type, 2020 (%)
CB-839
Copanlisib Hydrochloride
DI-B4
Entospletinib
Everolimus
FV-162
Others

Global Waldenstrom Macroglobulinemia Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Waldenstrom Macroglobulinemia Therapeutics Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others

Global Waldenstrom Macroglobulinemia Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Waldenstrom Macroglobulinemia Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Waldenstrom Macroglobulinemia Therapeutics revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Waldenstrom Macroglobulinemia Therapeutics revenues share in global market, 2020 (%)
Key companies Waldenstrom Macroglobulinemia Therapeutics sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Waldenstrom Macroglobulinemia Therapeutics sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
BeiGene (Beijing) Co.,Ltd
Calithera Biosciences, Inc.
Celgene Corporation
Genentech, Inc.
Genmab A/S
Gilead Sciences, Inc.
Hutchison MediPharma Limited
Idera Pharmaceuticals, Inc.
IGF Oncology, LLC.
Incyte Corporation
Karyopharm Therapeutics, Inc.
Merck KGaA
Millennium Pharmaceuticals, Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Waldenstrom Macroglobulinemia Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Waldenstrom Macroglobulinemia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Waldenstrom Macroglobulinemia Therapeutics Overall Market Size
2.1 Global Waldenstrom Macroglobulinemia Therapeutics Market Size: 2021 VS 2027
2.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Waldenstrom Macroglobulinemia Therapeutics Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Waldenstrom Macroglobulinemia Therapeutics Players in Global Market
3.2 Top Global Waldenstrom Macroglobulinemia Therapeutics Companies Ranked by Revenue
3.3 Global Waldenstrom Macroglobulinemia Therapeutics Revenue by Companies
3.4 Global Waldenstrom Macroglobulinemia Therapeutics Sales by Companies
3.5 Global Waldenstrom Macroglobulinemia Therapeutics Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Waldenstrom Macroglobulinemia Therapeutics Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Waldenstrom Macroglobulinemia Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Waldenstrom Macroglobulinemia Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Waldenstrom Macroglobulinemia Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Waldenstrom Macroglobulinemia Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Market Size Markets, 2021 & 2027
4.1.2 CB-839
4.1.3 Copanlisib Hydrochloride
4.1.4 DI-B4
4.1.5 Entospletinib
4.1.6 Everolimus
4.1.7 FV-162
4.1.8 Others
4.2 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share, 2016-2027
4.3 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Sales & Forecasts
4.3.1 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2021
4.3.2 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Sales, 2022-2027
4.3.3 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share, 2016-2027
4.4 By Type - Global Waldenstrom Macroglobulinemia Therapeutics Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share, 2016-2027
5.3 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Sales & Forecasts
5.3.1 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2021
5.3.2 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Sales, 2022-2027
5.3.3 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share, 2016-2027
5.4 By Application - Global Waldenstrom Macroglobulinemia Therapeutics Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share, 2016-2027
6.3 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Sales & Forecasts
6.3.1 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2021
6.3.2 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Sales, 2022-2027
6.3.3 By Region - Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2027
6.4.2 By Country - North America Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2027
6.4.3 US Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.4.4 Canada Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.4.5 Mexico Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2027
6.5.2 By Country - Europe Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2027
6.5.3 Germany Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.5.4 France Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.5.5 U.K. Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.5.6 Italy Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.5.7 Russia Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.5.8 Nordic Countries Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.5.9 Benelux Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2027
6.6.2 By Region - Asia Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2027
6.6.3 China Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.6.4 Japan Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.6.5 South Korea Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.6.6 Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.6.7 India Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2027
6.7.2 By Country - South America Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2027
6.7.3 Brazil Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.7.4 Argentina Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Waldenstrom Macroglobulinemia Therapeutics Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Waldenstrom Macroglobulinemia Therapeutics Sales, 2016-2027
6.8.3 Turkey Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.8.4 Israel Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.8.5 Saudi Arabia Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
6.8.6 UAE Waldenstrom Macroglobulinemia Therapeutics Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 BeiGene (Beijing) Co.,Ltd
7.1.1 BeiGene (Beijing) Co.,Ltd Corporate Summary
7.1.2 BeiGene (Beijing) Co.,Ltd Business Overview
7.1.3 BeiGene (Beijing) Co.,Ltd Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.1.4 BeiGene (Beijing) Co.,Ltd Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.1.5 BeiGene (Beijing) Co.,Ltd Key News
7.2 Calithera Biosciences, Inc.
7.2.1 Calithera Biosciences, Inc. Corporate Summary
7.2.2 Calithera Biosciences, Inc. Business Overview
7.2.3 Calithera Biosciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.2.4 Calithera Biosciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.2.5 Calithera Biosciences, Inc. Key News
7.3 Celgene Corporation
7.3.1 Celgene Corporation Corporate Summary
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.3.4 Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.3.5 Celgene Corporation Key News
7.4 Genentech, Inc.
7.4.1 Genentech, Inc. Corporate Summary
7.4.2 Genentech, Inc. Business Overview
7.4.3 Genentech, Inc. Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.4.4 Genentech, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.4.5 Genentech, Inc. Key News
7.5 Genmab A/S
7.5.1 Genmab A/S Corporate Summary
7.5.2 Genmab A/S Business Overview
7.5.3 Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.5.4 Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.5.5 Genmab A/S Key News
7.6 Gilead Sciences, Inc.
7.6.1 Gilead Sciences, Inc. Corporate Summary
7.6.2 Gilead Sciences, Inc. Business Overview
7.6.3 Gilead Sciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.6.4 Gilead Sciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.6.5 Gilead Sciences, Inc. Key News
7.7 Hutchison MediPharma Limited
7.7.1 Hutchison MediPharma Limited Corporate Summary
7.7.2 Hutchison MediPharma Limited Business Overview
7.7.3 Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.4.4 Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.7.5 Hutchison MediPharma Limited Key News
7.8 Idera Pharmaceuticals, Inc.
7.8.1 Idera Pharmaceuticals, Inc. Corporate Summary
7.8.2 Idera Pharmaceuticals, Inc. Business Overview
7.8.3 Idera Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.8.4 Idera Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.8.5 Idera Pharmaceuticals, Inc. Key News
7.9 IGF Oncology, LLC.
7.9.1 IGF Oncology, LLC. Corporate Summary
7.9.2 IGF Oncology, LLC. Business Overview
7.9.3 IGF Oncology, LLC. Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.9.4 IGF Oncology, LLC. Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.9.5 IGF Oncology, LLC. Key News
7.10 Incyte Corporation
7.10.1 Incyte Corporation Corporate Summary
7.10.2 Incyte Corporation Business Overview
7.10.3 Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.10.4 Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.10.5 Incyte Corporation Key News
7.11 Karyopharm Therapeutics, Inc.
7.11.1 Karyopharm Therapeutics, Inc. Corporate Summary
7.11.2 Karyopharm Therapeutics, Inc. Waldenstrom Macroglobulinemia Therapeutics Business Overview
7.11.3 Karyopharm Therapeutics, Inc. Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.11.4 Karyopharm Therapeutics, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.11.5 Karyopharm Therapeutics, Inc. Key News
7.12 Merck KGaA
7.12.1 Merck KGaA Corporate Summary
7.12.2 Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Business Overview
7.12.3 Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.12.4 Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.12.5 Merck KGaA Key News
7.13 Millennium Pharmaceuticals, Inc.
7.13.1 Millennium Pharmaceuticals, Inc. Corporate Summary
7.13.2 Millennium Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Business Overview
7.13.3 Millennium Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Major Product Offerings
7.13.4 Millennium Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales and Revenue in Global (2016-2021)
7.13.5 Millennium Pharmaceuticals, Inc. Key News
8 Global Waldenstrom Macroglobulinemia Therapeutics Production Capacity, Analysis
8.1 Global Waldenstrom Macroglobulinemia Therapeutics Production Capacity, 2016-2027
8.2 Waldenstrom Macroglobulinemia Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Waldenstrom Macroglobulinemia Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Waldenstrom Macroglobulinemia Therapeutics Supply Chain Analysis
10.1 Waldenstrom Macroglobulinemia Therapeutics Industry Value Chain
10.2 Waldenstrom Macroglobulinemia Therapeutics Upstream Market
10.3 Waldenstrom Macroglobulinemia Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Waldenstrom Macroglobulinemia Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Waldenstrom Macroglobulinemia Therapeutics in Global Market
Table 2. Top Waldenstrom Macroglobulinemia Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Waldenstrom Macroglobulinemia Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share by Companies, 2016-2021
Table 5. Global Waldenstrom Macroglobulinemia Therapeutics Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Waldenstrom Macroglobulinemia Therapeutics Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Waldenstrom Macroglobulinemia Therapeutics Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Waldenstrom Macroglobulinemia Therapeutics Product Type
Table 9. List of Global Tier 1 Waldenstrom Macroglobulinemia Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Waldenstrom Macroglobulinemia Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

BeiGene (Beijing) Co.,Ltd
Calithera Biosciences, Inc.
Celgene Corporation
Genentech, Inc.
Genmab A/S
Gilead Sciences, Inc.
Hutchison MediPharma Limited
Idera Pharmaceuticals, Inc.
IGF Oncology, LLC.
Incyte Corporation
Karyopharm Therapeutics, Inc.
Merck KGaA
Millennium Pharmaceuticals, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE